Insmed
INSM
$25.21
Share price
-2.33%
Change (1 day)
33.31%
Change (1 year)
Categories
Earnings for Insmed (INSM)
Earnings in 2023 (TTM): -$0.68 B
According to Insmed's latest financial reports the company's current earnings (TTM) are -$0.68 B. a decrease over its 2022 earnings that were of -$0.47 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Insmed from 2002 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$0.68 B | 45.77% |
| 2022 | -$0.47 B | 15.83% |
| 2021 | -$0.4 B | 50.19% |
| 2020 | -$0.27 B | 16.4% |
| 2019 | -$0.23 B | -23.9% |
| 2018 | -$0.3 B | 59.35% |
| 2017 | -$0.19 B | 8.52% |
| 2016 | -$0.18 B | 47.25% |
| 2015 | -$0.12 B | 34.53% |
| 2014 | -$87.17 M | 58.83% |
| 2013 | -$54.89 M | 35.14% |
| 2012 | -$40.62 M | -31.92% |
| 2011 | -$59.66 M | 854.92% |
| 2010 | -$6.25 M | -105.22% |
| 2009 | $0.11 B | |
| 2007 | -$20.44 M | -62.41% |
| 2006 | -$54.38 M | 98.19% |
| 2005 | -$27.44 M | 0.03% |
| 2004 | -$27.43 M | 159.07% |
| 2003 | -$10.59 M | -69.31% |
| 2002 | -$34.5 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $9.43 B | -1,507.07% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | $6.85 B | -1,122.58% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $4.42 B | -759.54% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -$0.53 B | -22.46% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | -$23.25 M | -96.54% | 🇺🇸 USA |
 Array Technologies ARRY | $0.21 B | -132.60% | 🇺🇸 USA |